| HOME | FOR PET OWNERS | CLINICAL SERVICES | FOR VETERINARY PROFESSIONALS | NEWS | CONTACT US | REQUEST FORMS |
| For Pet Owners |
| Meet our Specialists |
| How to find us? |
| Our facilities |
| About your first visit |
| Bert's Story |
| Testimonials |
| Help Page |
| FAQ Page |
| Feedback |
| Glossary, Qualifications |
| Glossary, Terms |
| Factsheets |
| Terms and Conditions |

Feline Injection Site Fibrosarcoma
Feline ‘Injection Site’ or ‘Vaccine Associated’ Fibrosarcoma is a rapidly progressive and aggressive tumour affecting cats.
On a deeply scientific level, the true cause of the disease is not yet understood but it is definitely associated with the administration of long-acting injections like vaccinations.
Vaccine technology has advanced since the condition was first reported in October 1991 and effective vaccinations now exist that have not yet been associated with this condition. If this condition arises then we believe that the patient can have a realistic chance of a continued good quality of life provided that rapid appropriate action is taken.
If you detect a subcutaneous swelling in your cat at a possible injection site we advise that the following actions are taken:
It is generally well recognised by veterinary oncologists that surgery offers the best chance of long term control. This is rarely so, however, if the surgery is not performed by an appropriately trained soft tissue surgeon.
At Davies Veterinary Specialists we are currently employing a combination therapy approach which harnesses the benefits of both chemotherapy and surgery for what is proving to be an improved outcome for the patients concerned. Unfortunately, this treatment strategy is not appropriate for all patients. It is important that we fully evaluate patients first to ensure that we do not risk prescribing treatment that would not ultimately help the individual patient. Such an evaluation might alter the general advice given above.
If you are concerned about the health of your pet you should contact your veterinary surgeon.